[Fremanezumab and erenumab for migraine prophylaxis - real-world data from Hungary].

Balogh E, Áfra J, Boór K, Bozsik G, Csáti A, Ertsey C, Héja M, Kellermann I, Kerényi L, Nagy F, Nagypál T, Ormayné Kovács G, Párdutz Á, Sinka B, Székely M, Szok D, Tajti J, Zsombók T.

Open source

DOI: 10.18071/isz.79.0189
Published: 2026-05-01
Container: Ideggyogy Sz
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.18071/isz.79.0189,
  title = {[Fremanezumab and erenumab for migraine prophylaxis - real-world data from Hungary].},
  author = {Balogh E and  Áfra J and  Boór K and  Bozsik G and  Csáti A and  Ertsey C and  Héja M and  Kellermann I and  Kerényi L and  Nagy F and  Nagypál T and  Ormayné Kovács G and  Párdutz Á and  Sinka B and  Székely M and  Szok D and  Tajti J and  Zsombók T.},
  year = {2026},
  journal = {Ideggyogy Sz},
  doi = {10.18071/isz.79.0189},
  url = {https://doi.org/10.18071/isz.79.0189}
}

RIS

TY  - JOUR
TI  - [Fremanezumab and erenumab for migraine prophylaxis - real-world data from Hungary].
AU  - Balogh E
AU  -  Áfra J
AU  -  Boór K
AU  -  Bozsik G
AU  -  Csáti A
AU  -  Ertsey C
AU  -  Héja M
AU  -  Kellermann I
AU  -  Kerényi L
AU  -  Nagy F
AU  -  Nagypál T
AU  -  Ormayné Kovács G
AU  -  Párdutz Á
AU  -  Sinka B
AU  -  Székely M
AU  -  Szok D
AU  -  Tajti J
AU  -  Zsombók T.
PY  - 2026
JO  - Ideggyogy Sz
DO  - 10.18071/isz.79.0189
UR  - https://doi.org/10.18071/isz.79.0189
ER  -

APA

E, B., J, Á., K, B., G, B., A, C., C, E., M, H., I, K., L, K., F, N., T, N., G, O. K., Á, P., B, S., M, S., D, S., J, T., & T., Z. (2026). [Fremanezumab and erenumab for migraine prophylaxis - real-world data from Hungary].. Ideggyogy Sz. https://doi.org/10.18071/isz.79.0189

Source records

europe-pmc · retrieved 2026-09-27T10:58:14.117Z